Please use this identifier to cite or link to this item:
|Title:||Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.|
Anavekar, Nagesh S
|Affiliation:||Department of Cardiology, Royal Darwin Hospital and Senior Lecturer, Flinders University, Darwin, N.T., Australia..|
|Citation:||Cardiorenal medicine 2012-12; 2(4): 281-297|
|Abstract:||Heart failure mortality is significantly increased in patients with baseline renal impairment and those with underlying heart failure who subsequently develop renal dysfunction. This accelerated progression occurs independent of the cause or grade of renal dysfunction and baseline risk factors. Recent large prospective databases have highlighted the depth of the current problem, while longitudinal population studies support an increasing disease burden. We have extensively reviewed the epidemiological and therapeutic data among these patients. The evidence points to a progression of heart failure early in renal impairment, even in the albuminuric stage. The data also support poor prescription of prognostic therapies. As renal function is the most important prognostic factor in heart failure, it is important to establish the current understanding of the disease burden and the therapeutic implications.|
|Appears in Collections:||NT Health digital library|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.